Bonifay Doctor Settles Controlled Substances Act Violations for $130,000 | USAO-NDFL

0

PENSACOLA, FLORIDA -Ahmad T. Ismail, 70, of Bonifay, Florida, settled potential violations of the Controlled Substances Act by agreeing to pay a $130,000 fine and waiving his registration with the Drug Enforcement Administration ( DEA). The settlement was announced by Jason R. Coody, United States Attorney for the Northern District of Florida.

“A physician’s failure to follow controlled substance law safeguards can facilitate the diversion of addictive drugs, the illegal distribution of these substances, and the risk of overdose,” U.S. Attorney Jason R. Coody said. “Along with our law enforcement partners, we will continue to use the civil and criminal provisions of the Controlled Substances Act to protect our communities and hold violators accountable.”

Ismail entered into a civil settlement agreement with the United States Attorney’s Office for the Northern District of Florida. The terms of the settlement include a provision that Ismail will relinquish his DEA registration and not reapply for a period of at least three years. Additionally, Ismail will pay a fine of $130,000.

Beginning in December 2018, DEA investigators conducted a routine inspection of Ismail’s practice in Bonifay, Florida. During this inspection and subsequent investigation, they uncovered numerous potential civil violations of the Controlled Substances Act, including:

  1. Failing to keep complete and accurate records revealing significant discrepancies between the number of dosage units in stock and the number of dosage units purchased using Dr. Ismail’s DEA registration number;
  2. Failure to carry out a biennial inventory;
  3. Failing to keep accurate and complete records of the dispensing/administration of controlled substances;
  4. Failing to keep complete and accurate dispensing records to include substance name, quantity, date dispensed, address of person to whom it was dispensed, written or typed name or person’s initials who dispensed the substance, drug strength and units in each container; and
  5. Failing to sign and date a controlled substance prescription on the date issued at least twice.

“As trusted members of the community, healthcare professionals are required to follow federal laws regarding controlled substances as set forth in the Controlled Substances Act,” said Deanne L. Reuter, Special Agent in Charge. of the DEA Field Division in Miami. “Our communities can be assured that the DEA will pursue civil actions against any DEA registrant who violates these federal laws as well as the trust of the American public.”

This civil settlement agreement is not an admission of liability by Dr. Ismail, nor a concession by the United States that its potential claims were without merit.

Assistant United States Attorneys Mary Ann Couch, Kathryn Drey and Marie Moyle represented the United States in the case, which was investigated by the Drug Enforcement Administration, Diversion Control Program.

The United States Attorney’s Office for the Northern District of Florida is one of 94 offices that serve as the nation’s leading litigants under the direction of the Attorney General. To access public court documents online, please visit the United States District Court for the Northern District of Florida website. For more information on the United States Attorney’s Office, Northern District of Florida, visit http://www.justice.gov/usao/fln/index.html.

Share.

About Author

Comments are closed.